Rating History for Ultragenyx Pharma (RARE) by Canaccord Genuity
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/18/2023 | Whitney Ijem | New Coverage | Buy (N/A) |
N/A (N/A) |
42.50 (48.41) |
13.91% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/18/2023 | Whitney Ijem | New Coverage | Buy (N/A) |
N/A (N/A) |
42.50 (48.41) |
13.91% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
